找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Erythropoietin; Wolfgang Jelkmann,Andreas J. Gross Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 anemia.blood.cells.c

[復(fù)制鏈接]
樓主: 調(diào)停
41#
發(fā)表于 2025-3-28 14:41:37 | 只看該作者
terleukin-3 (IL-3), the colony-stimulating factors (CSF) and erythropoietin (Epo) [8, 13, 62]. While the CSF induce the proliferation and differentiation of the pluripotent and committed progenitor cells [8], maturation of the late erythroid progenitors and erythroid precursors is mainly controlled by Epo [25].
42#
發(fā)表于 2025-3-28 21:48:36 | 只看該作者
Chemistry and Assays of Erythropoietin. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assay.
43#
發(fā)表于 2025-3-28 23:15:16 | 只看該作者
44#
發(fā)表于 2025-3-29 06:10:51 | 只看該作者
45#
發(fā)表于 2025-3-29 07:17:57 | 只看該作者
46#
發(fā)表于 2025-3-29 14:54:15 | 只看該作者
Recombinant Human Erythropoietinttention must be paid to its quality in the sense of a functional replacement of the natural hormone. Accordingly, a detailed comparison of the human urinary extracted form with the recombinant product is given. For better understanding, the efforts at cloning and expression of the hormone in various cellular systems are discussed.
47#
發(fā)表于 2025-3-29 17:50:07 | 只看該作者
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
48#
發(fā)表于 2025-3-29 20:51:12 | 只看該作者
49#
發(fā)表于 2025-3-30 02:50:41 | 只看該作者
50#
發(fā)表于 2025-3-30 07:07:47 | 只看該作者
Overview: 978-3-642-83747-0978-3-642-83745-6
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-21 22:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
林甸县| 屏东县| 璧山县| 疏附县| 孝义市| 福州市| 滦平县| 武乡县| 黎平县| 武威市| 嘉义市| 林芝县| 柘荣县| 抚顺市| 米林县| 昌邑市| 安丘市| 惠东县| 施秉县| 客服| 中牟县| 大英县| 墨竹工卡县| 福州市| 凌源市| 谢通门县| 建平县| 靖西县| 稻城县| 陆川县| 忻城县| 双柏县| 本溪| 南投县| 亚东县| 石城县| 泉州市| 菏泽市| 乌审旗| 巨野县| 门头沟区|